Journal of Current Glaucoma Practice

Register      Login

VOLUME 16 , ISSUE 3 ( September-December, 2022 ) > List of Articles


Acute Attack of Glaucoma after Scleral Melting and Iris Blockage of the Surgical Ostium: A Case Report of a Complication Derived from a Mitomycin C Supplemented Trabeculectomy

Jose A Paczka, Ana M Ponce-Horta, Andrea Tornero-Jimenez

Keywords : Bleb, Filtering surgery, Mitomycin C, Sclera, Trabeculectomy

Citation Information : Paczka JA, Ponce-Horta AM, Tornero-Jimenez A. Acute Attack of Glaucoma after Scleral Melting and Iris Blockage of the Surgical Ostium: A Case Report of a Complication Derived from a Mitomycin C Supplemented Trabeculectomy. J Curr Glaucoma Pract 2022; 16 (3):199-204.

DOI: 10.5005/jp-journals-10078-1373

License: CC BY-NC 4.0

Published Online: 23-01-2023

Copyright Statement:  Copyright © 2022; The Author(s).


Aim: To describe a case of an acute attack of glaucoma due to scleral melting in the area where a trabeculectomy was previously done. This condition resulted from the blockage of the surgical opening due to an iris prolapse in an eye that was previously supplemented with mitomycin C (MMC) during a filtering surgery and bleb needling revision. Case description: A 74-year-old Mexican female with a prior glaucoma diagnosis who assisted to an appointment presenting an acute ocular hypertensive crisis after several months of adequately controlled intraocular pressure (IOP). Ocular hypertension had been regulated after undergoing a trabeculectomy and bleb needling revision; both supplemented with MMC. The severe IOP increase occurred due to uveal tissue blockage in the filtering site, related to melting of the sclera in the same area. The patient was successfully treated through the use of a scleral patch graft and the implantation of an Ahmed valve. Conclusion: An acute attack of glaucoma associated with scleromalacia after trabeculectomy and needling has not been previously reported and is currently attributed to MMC supplementation. Nevertheless, the use of a scleral patch graft and further glaucoma surgery seems to be an efficient way to treat this condition. Clinical significance: Even though this complication was appropriately managed with this patient, we want to prevent further cases like this through the judicious and careful use of MMC.

PDF Share
  1. Arora KS, Robin AL, Corcoran KJ, et al. Use of various glaucoma surgeries and procedures in medicare beneficiaries from 1994 to 2012. Ophthalmology 2015;122(8):1615–1624. DOI: 10.1016/j.ophtha.2015.04.015
  2. Vinod K, Gedde SJ, Feuer WJ, et al. Practice preferences for glaucoma surgery: a survey of the American Glaucoma Society. J Glaucoma 2017;26(8):687–693. DOI: 10.1097/IJG.0000000000000720
  3. Cairns JE. Trabeculectomy. Preliminary report of a new method. Am J Ophthalmol 1968;66(4):673–679. DOI: 10.1016/0002-9394(68)91288-9
  4. Koryllos K. Trabeculectomy: a new glaucoma operation. Bull Soc Hellen Ophtalmol 1967;35:147–157.
  5. Holló G. Wound healing and glaucoma surgery: modulating the scarring process with conventional antimetabolites and new molecules. Dev Ophthalmol 2017;59:80–89. DOI: 10.1159/000458488
  6. Wilkins M, Wormald AI. Intraoperative mitomycin C for glaucoma surgery. Cochrane Database Syst Rev 2005;2005(4):CD002897. DOI: 10.1002/14651858.CD002897.pub2
  7. Green E, Wilkins M, Bunce C, et al. 5-fluorouracil for glaucoma surgery. Cochrane Database Syst Rev 2014;(2):CD001132. DOI: 10.1002/14651858.CD001132.pub2
  8. Cabourne E, Clarke JC, Schlottman PG, et al. Mitomycin-C versus 5-fluoracil for wound healing in glaucoma surgery. Cochrane Database Syst Rev 2015;(11):CD006259. DOI: 10.1002/14651858.CD006259.pub2
  9. Loon SC, Chew PT. A major review of antimetabolites in glaucoma therapy Ophthalmologica 1999;213(4):234–245. DOI: 10.1159/000027428
  10. Francis BA, Du LT, Najafi K, et al. Histopathologic features of conjunctival filtering blebs. Arch Ophthalmol 2005;123(2):166–170. DOI: 10.1001/archopht.123.2.166
  11. Wells AP, Cordeiro MF, Bunce C, et al. Cystic bleb formation and related complications in limbus- versus fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C. Ophthalmology 2003;110(11):2192–2197. DOI: 10.1016/S0161-6420(03)00800-5
  12. Solus JF, Jampel HD, Tracey PA, et al. Comparison of limbus-based and fornix-based trabeculectomy: success, bleb-related complications, and bleb morphology. Ophthalmology 2012;119(4):703–711. DOI: 10.1016/j.ophtha.2011.09.046
  13. Jampel HD, Solus JF, Tracey PA, et al. Outcomes and bleb-related complications of trabeculectomy. Ophthalmology 2012;119(4):712–722.DOI: 10.1016/j.ophtha.2011.09.049
  14. Mermoud A, Salmon JF, Murray AD. Trabeculectomy with mitomycin C for refractory glaucoma in blacks. Am J Ophthalmol 1993;116(1):72–78. DOI: 10.1016/s0002-9394(14)71747-7
  15. Akova YA, Koc F, Yalvac I, et al. Scleromalacia following trabeculectomy with intraoperative mitomycin C. Eur J Ophthalmol 1999;9(1):63–65.DOI: 10.1177/112067219900900110
  16. Coutinho I, Silva D, Mota M, et al. Reconstruction of delayed scleral flap melting with bovine pericardium after trabeculectomy with mitomycin C. GMS Ophthalmol Cases 2017;7:15. DOI: 10.3205/oc000066
  17. Riley DS, Barber MS, Kienle GS, et al. CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol 2017;89:218–235. DOI: 10.1016/j.jclinepi.2017.04.026
  18. Norliza WMW, Raihan IS, Azwa JA, et al. Scleral melting 16 years after pterygium excision with topical mitomycin C adjuvant therapy. Cont Lens Anterior Eye 2006;29(4):165–167. DOI: 10.1016/j.clae.2006.08.001
  19. Lindquist TP, Lee WB. Mitomycin C-associated scleral stromalysis after pterygium surgery. Cornea 2015;34(4):398–401. DOI: 10.1097/ICO.0000000000000384
  20. Rubinfeld RS, Pfister RR, Stein RM, et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology 1992;99(11):1647–1654. DOI: 10.1016/s0161-6420(92)31749-x
  21. Dougherty PJ, Hardten DR, Lindstrom RL. Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin-C. Cornea 1996;15(5):537–540. DOI: 10.1097/00003226-199609000-00015
  22. Fujitani A, Hayasaka S, Shibuya Y, et al. Corneoscleral ulceration and corneal perforation after pterygium excision and topical mitomycin C therapy. Ophthalmologica 1993;207(3):162–164. DOI: 10.1159/000310424
  23. Dadeya S, Fatima S. Corneoscleral perforation after pterygium excision and intraoperative mitomycin C. Ophthalmic Surg Lasers Imaging 2003;34(2):146–148. DOI: 10.3928/1542-8877-20030301-14
  24. Tsai YY, Lin JM, Shy JD. Acute scleral thinning after pterygium excision with intraoperative mitomycin C: a case report of scleral dellen after bare sclera technique and review of the literature. Cornea 2002;21(2):227–229. DOI: 10.1097/00003226-200203000-00022
  25. Esquenazi S. Autogenous lamellar scleral graft in the treatment of scleral melt after pterygium surgery. Graefes Arch Clin Exp Ophthalmol 2007;245(12):1869–1871. DOI: 10.1007/s00417-007-0693-3
  26. Crowston JG, Akbar AN, Constable PH, et al. Antimetabolite-induced apoptosis in Tenon's capsule fibroblasts. Invest Ophthalmol Vis Sci 1998;39(2):449–454. PMID: 9478007.
  27. Errico D, Scrimieri F, Riccardi R, et al. Trabeculectomy with double low dose of mitomycin C – two years of follow-up. Clin Ophthalmol 2011;5:1679–1681. DOI: 10.2147/OPTH.S25611
  28. Venkataraman P, Manapakkam M, Mohan N. Historical considerations and innovations in the perioperative use of mitomycin C for glaucoma filtration surgery and bleb revisions. J Glaucoma 2020;29(8):e94–e95. DOI: 10.1097/IJG.0000000000001556
  29. Mégevand GS, Salmon JF, Scholtz RP, et al. The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery. Ophthalmology 1995;102(1):84–90. DOI: 10.1016/s0161-6420(95)31049-4
  30. Khandelwal R, Bijlani M, Raje D, et al. Evaluating the efficacy of short duration Mitomycin C in safe surgery system trabeculectomy combined with cataract surgery. Clin Ophthalmol 2019;13:849–857. DOI: 10.2147/OPTH.S192044
  31. Guimaraes MEV, Soares-Bezerra BDP, Cordeiro FDM, et al. Glaucoma surgery with soaked sponges with mitomycin c vs sub-tenon injection: short-term outcomes. J Curr Glaucoma Pract 2019;13(2):50–54. DOI: 10.5005/jp-journals-10078-1254
  32. Pakravan M, Esfandiari H, Yazdani S, et al. Mitomycin C-augmented trabeculectomy: subtenon injection versus soaked sponges: a randomised clinical trial. Br J Ophthalmol 2017;101(9):1275–1280. DOI: 10.1136/bjophthalmol-2016-309671
  33. Sangwan VS, Jain V, Gupta P, Structural and functional outcome of scleral patch. Eye 2007;21(7):930–935. DOI: 10.1038/sj.eye.6702344
  34. Alvarado JA, Hollander DA, Juster RP, et al. Ahmed valve implantation with adjunctive mitomycin C and 5-fluorouracil: long-term outcomes. Am J Ophthalmology 2008;146(2):276–284. DOI: 10.1016/j.ajo.2008.04.008
  35. Costa VP, Azuara-Blanco A, Netland PA, et al. Efficacy and safety of adjunctive mitomycin C during Ahmed glaucoma valve implantation: a prospective randomized clinical trial. Ophthalmology 2004;111(6):1071–1076. DOI: 10.1016/j.ophtha.2003.09.037
  36. Susanna R Jr, Latin American Glaucoma Society Investigators. Partial Tenon's capsule resection with adjunctive mitomycin C in Ahmed glaucoma valve implant surgery. Br J Ophthalmol 2003;87(8):994–998. DOI: 10.1136/bjo.87.8.994
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.